Salt Lake City, Utah (July 2, 2014) – “Rich McKeown brings a deep understanding of the healthcare industry as the chief executive of one of the nation’s most respected healthcare consulting firms,” said ProLung President and CEO Steven Eror when he announced Leavitt Partners CEO Rich McKeown as the newest member of the Company’s board of directors.

“As Chief of Staff to US Department of Health and Human Services Secretary Mike Leavitt during the George W. Bush Administration, Mr. McKeown oversaw the daily operations of the Secretary, which included managing 27 federal agencies and overseeing the largest federal departmental budget. His insights and expertise will be valuable as we enter into an exciting phase of our Company’s growth and development with the launch of distribution and sales in Europe and our continued efforts to obtain the approvals required to market in the US.”

ProLung developed a patented, highly innovative, non-invasive, non-radiating Electro Pulmonary Nodule Scan, or EPN Scan, as an aid in the diagnosis of lung cancer, the deadliest form of cancer.  In Europe, the EPN Scan is marketed as FreshMedx. In the US, the Company plans to market the EPN Scan, subject to FDA approval, as ProLung.

In well-controlled clinical testing published in the Journal of Thoracic Oncology in 2012, the EPN Scan correctly categorized patients with malignant lung lesions with a 90% accuracy rate.

“At Leavitt Partners, we collaborate with clients and through our Health Intelligence Partners forum provide a window into the future of healthcare,” said McKeown. “The ProLung EPN device and Scan is the type of pioneering medical technology that we need available in the market to save lives.”

 

About ProLung: Known as ProLung in the US and Freshmedx in Europe, the Salt Lake City-based medical technology […]